Literature DB >> 1424105

Clinical utility of zinc protoporphyrin.

R F Labbé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1424105

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  7 in total

1.  Zinc protoporphyrin-trimethylamine-N-oxide complex involves cholesterol oxidation causing atherosclerosis.

Authors:  Navendu Paul; Rudra Sarkar; Sabyasachi Sarkar
Journal:  J Biol Inorg Chem       Date:  2021-03-13       Impact factor: 3.358

2.  Reticulocyte enrichment of zinc protoporphyrin/heme discriminates impaired iron supply during early development.

Authors:  Sharon E Blohowiak; Melinda E Chen; Kristin S Repyak; Nicole L Baumann-Blackmore; David P Carlton; Michael K Georgieff; Thomas D Crenshaw; Pamela J Kling
Journal:  Pediatr Res       Date:  2008-07       Impact factor: 3.756

3.  Zinc protoporphyrin regulates cyclin D1 expression independent of heme oxygenase inhibition.

Authors:  Ping La; Amal P Fernando; Zhi Wang; Ameen Salahudeen; Guang Yang; Qing Lin; Clyde J Wright; Phyllis A Dennery
Journal:  J Biol Chem       Date:  2009-10-22       Impact factor: 5.157

4.  Optimizing diagnostic biomarkers of iron deficiency anemia in community-dwelling Indian women and preschool children.

Authors:  Giridhar Kanuri; Deepti Chichula; Ritica Sawhney; Kevin Kuriakose; Sherwin De'Souza; Faye Pais; Karthika Arumugam; Arun S Shet
Journal:  Haematologica       Date:  2018-08-09       Impact factor: 9.941

5.  A "One-Stop" Screening Protocol for Haemoglobinopathy Traits and Iron Deficiency in Sri Lanka.

Authors:  Angela Allen; Shiromi Perera; Luxman Perera; Rexan Rodrigo; Sachith Mettananda; Agnes Matope; Ishari Silva; Nizri Hameed; Christopher A Fisher; Nancy Olivieri; David J Weatherall; Stephen Allen; Anuja Premawardhena
Journal:  Front Mol Biosci       Date:  2019-08-09

6.  Analysis of lead toxicity in human cells.

Authors:  Bruce S Gillis; Zarema Arbieva; Igor M Gavin
Journal:  BMC Genomics       Date:  2012-07-27       Impact factor: 3.969

7.  Heme and HO-1 Inhibition of HCV, HBV, and HIV.

Authors:  Warren N Schmidt; M Meleah Mathahs; Zhaowen Zhu
Journal:  Front Pharmacol       Date:  2012-10-04       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.